Deurali-Janta Pharmaceuticals Private Limited (DJPL) based in Kathmandu, Nepal is one of that country's leading pharmaceutical companies. DJPL manufactures and sells pharmaceutical formulations in Nepal and is preparing for international exports. DJPL is the first Nepalese pharmaceutical company awarded with World Health Organization - Good Manufacturing Practice (WHO-GMP) certificate. DJPL produces an extensive list of medications.
Background
Deurali-Janta Pharmaceuticals was established in Kathmandu by Mr. Hari Bhakta Sharma, executive director of the company, in 1988. DJPL started with a few over the counter products and antibiotics for minor ailments. In 2005, a specialized division, Suswasthya, was launched that focuses on cardiology and diebetology. In 2011, Aarogyam, a specialised division for dermatology products, followed. The Nirog Division was launched in June, 2013 with an investment of Rs 870 million. Deurali-Janta Pharmaceuticals is now one of the largest companies in Nepal. The company plans to export its products to at least five international markets within next 10 years. Deurali-Janta Pharmaceuticals was awarded best pharmaceutical company by Swasthya Khabar Patrika Health Award – 2012.